It is also becoming clear from such studies that RB1 and TP53 alterations are associated with prostate cancer lineage plasticity, transformation of prostate adenocarcinoma to an alternative lineage state no longer dependent on androgen receptor signaling. Here, RB1 is linked to prostate cancer.